Johnson & Johnson 

ARS26,040.00
43380
+ARS320.00+1.24% Thursday 20:00

Statistics

Day High
26,440
Day Low
25,700
52W High
28,720
52W Low
13,725
Volume
4,767
Avg. Volume
13,767
Mkt Cap
62.68T
P/E Ratio
15.98
Dividend Yield
1.98%
Dividend
515.27

Upcoming

Dividends

1.98%Dividend Yield
Jun 26
ARS128.82
Mar 26
ARS121.29
Dec 25
ARS124.80
Sep 25
ARS122.72
Jun 25
ARS102.94
10Y Growth
48.77%
5Y Growth
44.14%
3Y Growth
77.5%
1Y Growth
15.54%

Earnings

20OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
2.46
2.65
2.84
3.03
Expected EPS
3.027259
Actual EPS
N/A

Financials

27.35%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
119.18TRevenue
32.6TNet Income

Analyst Ratings

1,030.88Average Price Target
The highest estimate is 1,149.96.
From 15 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JNJ.BA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap137.76B
Pfizer competes directly with JNJ in the pharmaceuticals sector, offering a wide range of prescription drugs and vaccines.
Merck
MRK
Mkt Cap305.12B
Merck operates in the pharmaceutical industry, directly competing with JNJ in areas such as vaccines and prescription medications.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie, a research-based biopharmaceutical company, competes with JNJ in multiple therapeutic areas, including immunology and oncology.
Novartis
NVS
Mkt Cap293.94B
Novartis competes with JNJ in the healthcare sector, particularly in pharmaceuticals, offering drugs in areas like oncology and neurology.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, areas where JNJ is also a key player.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol Myers Squibb is a competitor in the pharmaceutical industry, offering prescription drugs in areas like cancer and cardiovascular diseases, similar to JNJ.
GSK
GSK
Mkt Cap105.71B
GlaxoSmithKline competes with JNJ in pharmaceuticals and consumer healthcare products, including vaccines and over-the-counter medicines.
Sanofi
SNY
Mkt Cap104.13B
Sanofi competes with JNJ in the pharmaceutical sector, particularly in areas like vaccines, rare diseases, and multiple sclerosis treatments.
AMGEN
AMGN
Mkt Cap196.12B
Amgen, a biopharmaceutical company, competes with JNJ in the development of innovative therapies, particularly in oncology and cardiology.
Abbott Laboratories
ABT
Mkt Cap163.61B
Abbott Laboratories competes with JNJ in the medical devices and diagnostics sectors, as well as in nutritional products and generic pharmaceuticals.

About

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Show more...
CEO
Mr. Joaquin Duato
Employees
141700
Country
United States
ISIN
ARDEUT110236

Listings

0 Comments

Share your thoughts

FAQ

What is Johnson & Johnson stock price today?
The current price of JNJ.BA is ARS26,040.00 ARS — it has increased by +1.24% in the past 24 hours. Watch Johnson & Johnson stock price performance more closely on the chart.
What is Johnson & Johnson stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Buenos Aires Exchange exchange Johnson & Johnson stocks are traded under the ticker JNJ.BA.
Is Johnson & Johnson stock price growing?
JNJ.BA stock has fallen by -2.84% compared to the previous week, the month change is a +11.28% rise, over the last year Johnson & Johnson has showed a +87% increase.
What is Johnson & Johnson market cap?
Today Johnson & Johnson has the market capitalization of 62.68T
When is the next Johnson & Johnson earnings date?
Johnson & Johnson is going to release the next earnings report on October 20, 2026.
What were Johnson & Johnson earnings last quarter?
JNJ.BA earnings for the last quarter are 4,280.41 ARS per share, whereas the estimation was 4,213.31 ARS resulting in a +1.59% surprise. The estimated earnings for the next quarter are N/A ARS per share.
What is Johnson & Johnson revenue for the last year?
Johnson & Johnson revenue for the last year amounts to 119.18T ARS.
What is Johnson & Johnson net income for the last year?
JNJ.BA net income for the last year is 32.6T ARS.
Does Johnson & Johnson pay dividends?
Yes, JNJ.BA dividends are paid quarterly. The last dividend per share was 128.82 ARS. As of today, Dividend Yield (FWD)% is 1.98%.
How many employees does Johnson & Johnson have?
As of July 17, 2026, the company has 141,700 employees.
In which sector is Johnson & Johnson located?
Johnson & Johnson operates in the Health & Wellness sector.
When did Johnson & Johnson complete a stock split?
Johnson & Johnson has not had any recent stock splits.
Where is Johnson & Johnson headquartered?
Johnson & Johnson is headquartered in New Brunswick, United States.